PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-85.88%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.49%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-63.49%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
-59.91%
Both companies reducing D&A. Martin Whitman would check industry patterns.
136.73%
EBITDA growth exceeding 1.5x CRN.AX's 6.09%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
43.03%
Operating income growth while CRN.AX declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
642.93%
Other expenses growth above 1.5x CRN.AX's 71.85%. Michael Burry would check for concerning trends.
93.56%
Pre-tax income growth exceeding 1.5x CRN.AX's 55.66%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-114.78%
Both companies reducing tax expense. Martin Whitman would check patterns.
98.33%
Net income growth exceeding 1.5x CRN.AX's 47.33%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
98.37%
EPS growth exceeding 1.5x CRN.AX's 47.22%. David Dodd would verify competitive advantages.
98.37%
Diluted EPS growth exceeding 1.5x CRN.AX's 47.31%. David Dodd would verify competitive advantages.
4.91%
Share count increase while CRN.AX reduces shares. John Neff would investigate differences.
4.91%
Diluted share change of 4.91% while CRN.AX is stable. Bruce Berkowitz would verify approach.